Literature DB >> 20437025

[Long-term care after deep brain stimulation of patients with Parkinson's disease].

F Sixel-Döring1, G Ebersbach.   

Abstract

Long-term care after deep brain stimulation for Parkinson's disease requires regular technical check-ups as well as clinical follow-up. Residual or emerging difficulties with gait, balance or speech should be addressed by specific rehabilitation programs. In cases of psychosocial maladjustment, psychotherapy or family counseling may prove helpful. After consolidation of stimulation parameters, pharmacotherapy can be tailored according to the individual needs, following the same guidelines as for Parkinson's disease patients without deep brain stimulation. In cases of clinical deterioration, malfunctioning of the stimulation system, comorbidity or disease progression has to be considered and treated accordingly. Structured long-term care programs may contribute to patient satisfaction and ensure quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437025     DOI: 10.1007/s00115-010-2940-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  30 in total

Review 1.  Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.

Authors:  Galit Kleiner-Fisman; Jan Herzog; David N Fisman; Filippo Tamma; Kelly E Lyons; Rajesh Pahwa; Anthony E Lang; Günther Deuschl
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

2.  Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect.

Authors:  C Granziera; C Pollo; H Russmann; C Staedler; J Ghika; J-G Villemure; P R Burkhard; F J G Vingerhoets
Journal:  Parkinsonism Relat Disord       Date:  2007-12-11       Impact factor: 4.891

3.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

4.  Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease.

Authors:  J A Saint-Cyr; L L Trépanier; R Kumar; A M Lozano; A E Lang
Journal:  Brain       Date:  2000-10       Impact factor: 13.501

5.  Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease.

Authors:  L L Trépanier; R Kumar; A M Lozano; A E Lang; J A Saint-Cyr
Journal:  Brain Cogn       Date:  2000-04       Impact factor: 2.310

6.  Behavioural disorders, Parkinson's disease and subthalamic stimulation.

Authors:  J L Houeto; V Mesnage; L Mallet; B Pillon; M Gargiulo; S Tezenas du Moncel; A M Bonnet; B Pidoux; D Dormont; P Cornu; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 7.  Physical therapy in Parkinson's disease: evolution and future challenges.

Authors:  Samyra H J Keus; Marten Munneke; Maarten J Nijkrake; Gert Kwakkel; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

8.  Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.

Authors:  M Zibetti; M Pesare; A Cinquepalmi; M Rosso; L Castelli; L Rizzi; B Bergamasco; M Lanotte; L Lopiano
Journal:  Parkinsonism Relat Disord       Date:  2008-06-02       Impact factor: 4.891

9.  [Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association].

Authors:  R Hilker; R Benecke; G Deuschl; W Fogel; A Kupsch; C Schrader; F Sixel-Döring; L Timmermann; J Volkmann; M Lange
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

10.  Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

Authors:  Selma Aybek; Aline Gronchi-Perrin; Alexandre Berney; Sabina Catalano Chiuvé; Jean-Guy Villemure; Pierre R Burkhard; François J G Vingerhoets
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.